Occupational Medicines Market by Application (Chemical Poisoning, Psychological Disorder, Noise-Induced Hearing Loss & Vibration, Skin Disorder, Chronic Respiratory Disease, Pneumoconiosis, Musculoskeletal Disorder, Cancer, and Others), and Industry (Agriculture & Forestry, Construction, Manufacturing, Petroleum & Mining, Transportation, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025
- ALL2658365
- 220 Pages
- July 2018
- Pharmaceuticals
Occupational medicines are drugs used to treat patients with work-related diseases and illnesses. The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach at $5,794 million by 2025, registering a CAGR of 5.5% from 2018 to 2025.
Rapid increase in the aging workforce and a favorable regulatory environment toward occupational medicines supplement the growth of the market. Furthermore, rise in awareness about occupational health is one of the significant factors that drives the market growth.
However, surge in incorporation of automation and artificial intelligence (AI) at the workplace, emergence of small businesses, and change in industry structure are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand for occupational medicines are expected to provide new opportunities for the market players during the forecast period.
The global occupational medicines market is segmented based on application, industry, and region. On the basis of application, the market is divided into chemical poisoning, psychological disorder, non-induced hearing loss & vibration, skin disorder, chronic respiratory disease, pneumoconiosis, musculoskeletal disorder, cancer, and other applications.
By industry, it is categorized into agriculture & forestry, construction, manufacturing, petroleum & mining, transportation, and others. Region-wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis of the overall market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global occupational medicines market.
- Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
- An in-depth analysis based on region is provided to understand the regional market and facilitate the strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By application
- Chemical poisoning
- Psychological disorder
- Non-Induced hearing loss & vibration
- Skin disorder
- Chronic respiratory disease
- Pneumoconiosis
- Musculoskeletal disorder
- Cancer
- Others
By industry
- Agriculture & forestry
- Construction
- Manufacturing
- Petroleum & mining
- Transportation
- Others
By region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
The list of key players operating in this market includes:
- Johnson & Johnson
- Pfizer, Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Novartis International AG
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Amgen, Inc.
- AstraZeneca
- Sanofi SA
The other players included in the value chain analysis (and not included in the report) include:
- Merck & Co., Inc.
- AbbVie, Inc.
- GlaxoSmithKline plc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in awareness about occupational health
3.4.1.2. Favorable regulatory environment
3.4.1.3. Rapid increase in aging workforce
3.4.2. Restraints
3.4.2.1. Emergence of small businesses and change in industry structure
3.4.2.2. Rise in incorporation of artificial intelligence (AI) and automation in the industry
3.4.3. Opportunity
3.4.3.1. Untapped potential of the emerging economies
CHAPTER 4: OCCUPATIONAL MEDICINES MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Chemical poisoning
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Psychological disorder
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Non-induced hearing loss & vibration
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Skin disorder
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Chronic respiratory disease
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Pneumoconiosis
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Musculoskeletal disorder
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Cancer
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. Others
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
CHAPTER 5: OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Agriculture & forestry
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Construction
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Manufacturing
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Petroleum & mining
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Transportation
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
5.7. Other industries
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country
CHAPTER 6: OCCUPATIONAL MEDICINES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America occupational medicines market size and forecast, by country
6.2.2.1. U.S. market size and forecast
6.2.2.1.1. U.S. occupational medicines market, by industry
6.2.2.1.2. U.S. occupational medicines market, by application
6.2.2.2. Canada market size and forecast
6.2.2.2.1. Canada occupational medicines market, by industry
6.2.2.2.2. Canada occupational medicines market, by application
6.2.2.3. Mexico market size and forecast
6.2.2.3.1. Mexico occupational medicines market, by industry
6.2.2.3.2. Mexico occupational medicines market, by application
6.2.3. North America occupational medicines market size and forecast, by application
6.2.4. North America occupational medicines market size and forecast, by industry
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Europe occupational medicines market size and forecast, by country
6.3.2.1. Germany market size and forecast
6.3.2.1.1. Germany occupational medicines market, by industry
6.3.2.1.2. Germany occupational medicines market, by application
6.3.2.2. France market size and forecast
6.3.2.2.1. France occupational medicines market, by industry
6.3.2.2.2. France occupational medicines market, by application
6.3.2.3. UK market size and forecast
6.3.2.3.1. UK occupational medicines market, by industry
6.3.2.3.2. UK occupational medicines market, by application
6.3.2.4. Italy market size and forecast
6.3.2.4.1. Italy occupational medicines market, by industry
6.3.2.4.2. Italy occupational medicines market, by application
6.3.2.5. Spain market size and forecast
6.3.2.5.1. Spain occupational medicines market, by industry
6.3.2.5.2. Spain occupational medicines market, by application
6.3.2.6. Rest of Europe market size and forecast
6.3.2.6.1. Rest of Europe occupational medicines market, by industry
6.3.2.6.2. Rest of Europe occupational medicines market, by application
6.3.3. Europe occupational medicines market size and forecast, by application
6.3.4. Europe occupational medicines market size and forecast, by industry
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Asia-Pacific occupational medicines market size and forecast, by country
6.4.2.1. Japan market size and forecast
6.4.2.1.1. Japan occupational medicines market, by industry
6.4.2.1.2. Japan occupational medicines market, by application
6.4.2.2. China market size and forecast
6.4.2.2.1. China occupational medicines market, by industry
6.4.2.2.2. China occupational medicines market, by application
6.4.2.3. India market size and forecast
6.4.2.3.1. India occupational medicines market, by industry
6.4.2.3.2. India occupational medicines market, by application
6.4.2.4. Australia market size and forecast
6.4.2.4.1. Australia occupational medicines market, by industry
6.4.2.4.2. Australia occupational medicines market, by application
6.4.2.5. South Korea market size and forecast
6.4.2.5.1. South Korea occupational medicines market, by industry
6.4.2.5.2. South Korea occupational medicines market, by application
6.4.2.6. Rest of Asia-Pacific market size and forecast
6.4.2.6.1. Rest of Asia-Pacific occupational medicines market, by industry
6.4.2.6.2. Rest of Asia-Pacific occupational medicines market, by application
6.4.3. Asia-Pacific occupational medicines market size and forecast, by application
6.4.4. Asia-Pacific occupational medicines market size and forecast, by industry
6.5. LAMEA
6.5.1. Key market trends
6.5.2. LAMEA occupational medicines market size and forecast, by country
6.5.2.1. Brazil market size and forecast
6.5.2.1.1. Brazil occupational medicines market, by industry
6.5.2.1.2. Brazil occupational medicines market, by application
6.5.2.2. Saudi Arabia market size and forecast
6.5.2.2.1. Saudi Arabia occupational medicines market, by industry
6.5.2.2.2. Saudi Arabia occupational medicines market, by application
6.5.2.3. South Africa market size and forecast
6.5.2.3.1. South Africa occupational medicines market, by industry
6.5.2.3.2. South Africa occupational medicines market, by application
6.5.2.4. Rest of LAMEA market size and forecast
6.5.2.4.1. Rest of LAMEA occupational medicines market, by industry
6.5.2.4.2. Rest of LAMEA occupational medicines market, by application
6.5.3. LAMEA occupational medicines market size and forecast, by application
6.5.4. LAMEA occupational medicines market size and forecast, by industry
CHAPTER 7: COMPANY PROFILES
7.1. Amgen Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. AstraZeneca PLC
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Bristol-Myers Squibb Company
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Eli Lilly and Company
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. F. Hoffmann-La Roche Ltd.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. Johnson & Johnson
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5.
7.6.6. Business performance
7.6.7. Key strategic moves and developments
7.7. Nestl S.A. (Galderma S.A.)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5.
7.7.6. Business performance
7.7.7. Key strategic moves and developments
7.8. Novartis AG
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.9. Pfizer Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5.
7.9.6. Business performance
7.10. Sanofi
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5.
7.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 02. OCCUPATIONAL MEDICINES MARKET FOR CHEMICAL POISONING, BY REGION, 2017-2025 ($MILLION)
TABLE 03. OCCUPATIONAL MEDICINES MARKET FOR PSYCHOLOGICAL DISORDERS, BY REGION, 2017-2025 ($MILLION)
TABLE 04. OCCUPATIONAL MEDICINES MARKET FOR NON-INDUCED HEARING LOSS & VIBRATION, BY REGION, 2017-2025 ($MILLION)
TABLE 05. OCCUPATIONAL MEDICINES MARKET FOR SKIN DISORDERS, BY REGION, 2017-2025 ($MILLION)
TABLE 06. OCCUPATIONAL MEDICINES MARKET FOR CHRONIC RESPIRATORY DISEASE, BY REGION, 2017-2025 ($MILLION)
TABLE 07. OCCUPATIONAL MEDICINES MARKET FOR PNEUMOCONIOSIS, BY REGION, 2017-2025 ($MILLION)
TABLE 08. OCCUPATIONAL MEDICINES MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2017-2025 ($MILLION)
TABLE 09. OCCUPATIONAL MEDICINES MARKET FOR CANCER, BY REGION, 2017-2025 ($MILLION)
TABLE 10. OCCUPATIONAL MEDICINES MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 12. OCCUPATIONAL MEDICINES MARKET FOR AGRICULTURE & FORESTRY INDUSTRY, BY REGION, 2017-2025 ($MILLION)
TABLE 13. OCCUPATIONAL MEDICINES MARKET FOR CONSTRUCTION INDUSTRY, BY REGION, 2017-2025 ($MILLION)
TABLE 14. OCCUPATIONAL MEDICINES MARKET FOR MANUFACTURING INDUSTRY, BY REGION, 2017-2025 ($MILLION)
TABLE 15. OCCUPATIONAL MEDICINES MARKET FOR PETROLEUM & MINING INDUSTRY, BY REGION, 2017-2025 ($MILLION)
TABLE 16. OCCUPATIONAL MEDICINES MARKET FOR TRANSPORTATION INDUSTRY, BY REGION, 2017-2025 ($MILLION)
TABLE 17. OCCUPATIONAL MEDICINES MARKET FOR OTHER INDUSTRIES, BY REGION, 2017-2025 ($MILLION)
TABLE 18. OCCUPATIONAL MEDICINES MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 19. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 20. U.S. OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 21. U.S. OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 23. CANADA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 24. MEXICO OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 25. MEXICO OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 26. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 27. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 28. EUROPE OCCUPATIONAL MEDICINES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 29. GERMANY OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 30. GERMANY OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 32. FRANCE OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 33. UK OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 34. UK OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 35. ITALY OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 36. ITALY OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 37. SPAIN OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 38. SPAIN OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 39. REST OF EUROPE OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 40. REST OF EUROPE OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 41. EUROPE OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. EUROPE OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 43. ASIA-PACIFIC OCCUPATIONAL MEDICINES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 44. JAPAN OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 46. CHINA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 47. CHINA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. INDIA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 49. INDIA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 50. AUSTRALIA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 51. AUSTRALIA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 52. SOUTH KOREA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 53. SOUTH KOREA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 54. REST OF ASIA-PACIFIC OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 56. ASIA-PACIFIC OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 57. ASIA-PACIFIC OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 58. LAMEA OCCUPATIONAL MEDICINES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 59. BRAZIL OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 60. BRAZIL OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. SAUDI ARABIA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 62. SAUDI ARABIA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 63. SOUTH AFRICA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 64. SOUTH AFRICA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 65. REST OF LAMEA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 66. REST OF LAMEA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 67. LAMEA OCCUPATIONAL MEDICINES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 68. LAMEA OCCUPATIONAL MEDICINES MARKET, BY INDUSTRY, 2017-2025 ($MILLION)
TABLE 69. AMGEN: COMPANY SNAPSHOT
TABLE 70. AMGEN: PRODUCT PORTFOLIO
TABLE 71. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 72. ASTRAZENECA: OPERATING SEGMENTS
TABLE 73. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 74. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
TABLE 75. BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO
TABLE 76. LILLY: COMPANY SNAPSHOT
TABLE 77. LILLY: OPERATING SEGMENTS
TABLE 78. LILLY: PRODUCT PORTFOLIO
TABLE 79. ROCHE: COMPANY SNAPSHOT
TABLE 80. ROCHE: OPERATING SEGMENTS
TABLE 81. ROCHE: PRODUCT PORTFOLIO
TABLE 82. J&J: COMPANY SNAPSHOT
TABLE 83. J&J: OPERATING SEGMENTS
TABLE 84. J&J: PRODUCT PORTFOLIO
TABLE 85. NESTL: COMPANY SNAPSHOT
TABLE 86. NESTL: OPERATING SEGMENTS
TABLE 87. NESTL: PRODUCT PORTFOLIO
TABLE 88. NOVARTIS: COMPANY SNAPSHOT
TABLE 89. NOVARTIS: OPERATING SEGMENTS
TABLE 90. NOVARTIS: PRODUCT PORTFOLIO
TABLE 91. PFIZER: COMPANY SNAPSHOT
TABLE 92. PFIZER: OPERATING SEGMENTS
TABLE 93. PFIZER: PRODUCT PORTFOLIO
TABLE 94. SANOFI: COMPANY SNAPSHOT
TABLE 95. SANOFI: OPERATING SEGMENTS
TABLE 96. SANOFI: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. OCCUPATIONAL MEDICINES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018*
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. OCCUPATIONAL MEDICINES MARKET: IMPACT ANALYSIS
FIGURE 08. ELDERLY POPULATION (AGED 65 AND ABOVE), BY GEOGRAPHY, 2015, 2030, AND 2050
FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR CHEMICAL POISONING, 2017 AND 2025 ($MILLION)
FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR PSYCHOLOGICAL DISORDERS, 2017 AND 2025 ($MILLION)
FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR NON-INDUCED HEARING LOSS & VIBRATION, 2017 AND 2025 ($MILLION)
FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR SKIN DISORDERS, 2017 AND 2025 ($MILLION)
FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR CHRONIC RESPIRATORY DISEASE, 2017 AND 2025 ($MILLION)
FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR PNEUMOCONIOSIS, 2017 AND 2025 ($MILLION)
FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR MUSCULOSKELETAL DISORDERS, 2017 AND 2025 ($MILLION)
FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR CANCER, 2017 AND 2025 ($MILLION)
FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR OTHER APPLICATIONS, 2017 AND 2025 ($MILLION)
FIGURE 18. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR AGRICULTURE & FORESTRY INDUSTRY, 2017 AND 2025 ($MILLION)
FIGURE 19. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR CONSTRUCTION INDUSTRY, 2017 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MARKET FOR MANUFACTURING INDUSTRY 2017 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET FOR PETROLEUM & MINING INDUSTRY, 2017 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES FOR TRANSPORTATION INDUSTRY, 2017 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE COUNTRY ANALYSIS OF OCCUPATIONAL MEDICINES MARKET OTHER INDUSTRIES, 2017 AND 2025 ($MILLION)
FIGURE 24. AMGEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 25. AMGEN: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 26. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. ASTRAZENECA: REVENUE, 2015-2017 ($MILLION)
FIGURE 28. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. REVENUE, 2015-2017 ($MILLION)
FIGURE 30. BRISTOL-MYERS SQUIBB: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 31. REVENUE, 2015-2017 ($MILLION)
FIGURE 32. LILLY: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. LILLY: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 34. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. J&J: REVENUE, 2015-2017 ($MILLION)
FIGURE 38. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. NESTL: REVENUE, 2015-2017 ($MILLION)
FIGURE 41. NESTL: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 42. NESTL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. NET SALES, 2015-2017 ($MILLION)
FIGURE 44. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. PFIZER: REVENUE, 2015-2017 ($MILLION)
FIGURE 47. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. SANOFI: NET SALES, 2015-2017 ($MILLION)
FIGURE 50. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
